Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients von Janku, Filip

Volltext

Targeting the PI3K pathway in cancer: are we making headway? von Janku, Filip, Yap, Timothy A., Meric-Bernstam, Funda

Volltext

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway von POLIVKA, Jiri, JANKU, Filip

Volltext

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages von Emile, Jean-François, Abla, Oussama, Fraitag, Sylvie, Horne, Annacarin, Haroche, Julien, Donadieu, Jean, Requena-Caballero, Luis, Jordan, Michael B., Abdel-Wahab, Omar, Allen, Carl E., Charlotte, Frédéric, Diamond, Eli L., Egeler, R.Maarten, Fischer, Alain, Herrera, Juana Gil, Henter, Jan-Inge, Janku, Filip, Merad, Miriam, Picarsic, Jennifer, Rodriguez-Galindo, Carlos, Rollins, Barret J., Tazi, Abdellatif, Vassallo, Robert, Weiss, Lawrence M.

Volltext

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era von Goyal, Gaurav, Heaney, Mark L., Collin, Matthew, Cohen-Aubart, Fleur, Vaglio, Augusto, Durham, Benjamin H., Hershkovitz-Rokah, Oshrat, Girschikofsky, Michael, Jacobsen, Eric D., Toyama, Kazuhiro, Goodman, Aaron M., Hendrie, Paul, Cao, Xin-xin, Estrada-Veras, Juvianee I., Shpilberg, Ofer, Abdo, André, Kurokawa, Mineo, Dagna, Lorenzo, McClain, Kenneth L., Mazor, Roei D., Picarsic, Jennifer, Janku, Filip, Go, Ronald S., Haroche, Julien, Diamond, Eli L.

Volltext

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials von Meric-Bernstam, Funda, Brusco, Lauren, Shaw, Kenna, Horombe, Chacha, Kopetz, Scott, Davies, Michael A, Routbort, Mark, Piha-Paul, Sarina A, Janku, Filip, Ueno, Naoto, Hong, David, De Groot, John, Ravi, Vinod, Li, Yisheng, Luthra, Raja, Patel, Keyur, Broaddus, Russell, Mendelsohn, John, Mills, Gordon B

Volltext

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease von Diamond, Eli L., Dagna, Lorenzo, Hyman, David M., Cavalli, Giulio, Janku, Filip, Estrada-Veras, Juvianee, Ferrarini, Marina, Abdel-Wahab, Omar, Heaney, Mark L., Scheel, Paul J., Feeley, Nancy K., Ferrero, Elisabetta, McClain, Kenneth L., Vaglio, Augusto, Colby, Thomas, Arnaud, Laurent, Haroche, Julien

Volltext

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative von TSIMBERIDOU, Apostolia-Maria, ISKANDER, Nancy G, YANG YE, SIJIN WEN, BERRY, Donald, KURZROCK, Razelle, HONG, David S, WHELER, Jennifer J, FALCHOOK, Gerald S, SIQING FU, PIHA-PAUL, Sarina, NAING, Aung, JANKU, Filip, LUTHRA, Rajyalakshmi

Volltext

Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial von How, Jeffrey A., Jazaeri, Amir A., Soliman, Pamela T., Fleming, Nicole D., Gong, Jing, Piha-Paul, Sarina A., Janku, Filip, Stephen, Bettzy, Naing, Aung

Volltext

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants von Smith, Bryan D., Kaufman, Michael D., Lu, Wei-Ping, Gupta, Anu, Leary, Cynthia B., Wise, Scott C., Rutkoski, Thomas J., Ahn, Yu Mi, Al-Ani, Gada, Bulfer, Stacie L., Caldwell, Timothy M., Chun, Lawrence, Ensinger, Carol L., Hood, Molly M., McKinley, Arin, Patt, William C., Ruiz-Soto, Rodrigo, Su, Ying, Telikepalli, Hanumaiah, Town, Ajia, Turner, Benjamin A., Vogeti, Lakshminarayana, Vogeti, Subha, Yates, Karen, Janku, Filip, Abdul Razak, Albiruni Ryan, Rosen, Oliver, Heinrich, Michael C., Flynn, Daniel L.

Volltext

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study von Wheler, Jennifer J, Janku, Filip, Naing, Aung, Li, Yali, Stephen, Bettzy, Zinner, Ralph, Subbiah, Vivek, Fu, Siqing, Karp, Daniel, Falchook, Gerald S, Tsimberidou, Apostolia M, Piha-Paul, Sarina, Anderson, Roosevelt, Ke, Danxia, Miller, Vincent, Yelensky, Roman, Lee, J Jack, Hong, David S, Kurzrock, Razelle

Volltext

Associations between the gut microbiome and fatigue in cancer patients von Hajjar, Joud, Mendoza, Tito, Zhang, Liangliang, Fu, Siqing, Piha-Paul, Sarina A., Hong, David S., Janku, Filip, Karp, Daniel D., Ballhausen, Alexej, Gong, Jing, Zarifa, Abdulrazzak, Peterson, Christine B., Meric-Bernstam, Funda, Jenq, Robert, Naing, Aung

Volltext

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers von Möhrmann, Lino, Huang, Helen J, Hong, David S, Tsimberidou, Apostolia M, Fu, Siqing, Piha-Paul, Sarina A, Subbiah, Vivek, Karp, Daniel D, Naing, Aung, Krug, Anne, Enderle, Daniel, Priewasser, Tina, Noerholm, Mikkel, Eitan, Erez, Coticchia, Christine, Stoll, Georg, Jordan, Lisa-Marie, Eng, Cathy, Kopetz, E Scott, Skog, Johan, Meric-Bernstam, Funda, Janku, Filip

Volltext

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers von Groisberg, Roman, Hong, David S, Roszik, Jason, Janku, Filip, Tsimberidou, Apostolia M, Javle, Milind, Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms von Diamond, Eli L, Durham, Benjamin H, Haroche, Julien, Yao, Zhan, Ma, Jing, Parikh, Sameer A, Wang, Zhaoming, Choi, John, Kim, Eunhee, Cohen-Aubart, Fleur, Lee, Stanley Chun-Wei, Gao, Yijun, Micol, Jean-Baptiste, Campbell, Patrick, Walsh, Michael P, Sylvester, Brooke, Dolgalev, Igor, Aminova, Olga, Heguy, Adriana, Zappile, Paul, Nakitandwe, Joy, Ganzel, Chezi, Dalton, James D, Ellison, David W, Estrada-Veras, Juvianee, Lacouture, Mario, Gahl, William A, Stephens, Philip J, Miller, Vincent A, Ross, Jeffrey S, Ali, Siraj M, Briggs, Samuel R, Fasan, Omotayo, Block, Jared, Héritier, Sebastien, Donadieu, Jean, Solit, David B, Hyman, David M, Baselga, José, Janku, Filip, Taylor, Barry S, Park, Christopher Y, Amoura, Zahir, Dogan, Ahmet, Emile, Jean-Francois, Rosen, Neal, Gruber, Tanja A, Abdel-Wahab, Omar

Volltext

Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences von Yao, Shuyang, Meric-Bernstam, Funda, Hong, David, Janku, Filip, Naing, Aung, Piha-Paul, Sarina Anne, Tsimberidou, Apostolia Maria, Karp, Daniel, Subbiah, Vivek, Yap, Timothy Anthony, Ahnert, Jordi Rodon, Pant, Shubham, Dumbrava, Ecaterina E Ileana, Wathoo, Chetna, Campbell, Erick, Yu, Lihou, Yamamura, Yuko, Fu, Siqing

Volltext

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study von Hong, David S, Prof, Hui, David, MD, Bruera, Eduardo, Prof, Janku, Filip, MD, Naing, Aung, MD, Falchook, Gerald S, MD, Piha-Paul, Sarina, MD, Wheler, Jennifer J, MD, Fu, Siqing, MD, Tsimberidou, Apostolia M, MD, Stecher, Michael, MD, Mohanty, Prasant, MBBS, Simard, John, BSc, Kurzrock, Razelle, Prof

Volltext

HER2/neu-directed therapy for biliary tract cancer von Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C, Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A, Kaseb, Ahmed O, Thomas, Melanie B, Siegel, Abby B

Volltext

Erdheim-Chester Disease: Characteristics and Management von Munoz, Javier, MD, FACP, Janku, Filip, MD, PhD, Cohen, Philip R., MD, Kurzrock, Razelle, MD

Volltext

Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm von Turski, Michelle L, Vidwans, Smruti J, Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Subbiah, Vivek, Rodon, Jordi, Kurzrock, Razelle

Volltext